Related Experiment Video
Updated: Nov 2, 2025

07:41
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
2.6K
Cutaneous Melanoma Classification: The Importance of High-Throughput Genomic Technologies
Cristian Scatena1, Daniela Murtas2, Sara Tomei3
1Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Frontiers in Oncology
|June 14, 2021
Summary
This review covers cutaneous melanoma, its genetic alterations, and targeted therapies. It also explores advanced genomic technologies for personalized melanoma treatment and management.
Area of Science:
- Oncology
- Genomics
- Dermatology
Background:
- Cutaneous melanoma is a deadly skin cancer with significant mortality.
- Recent advances in understanding melanoma genetics have improved treatment strategies.
- Genomic technologies have revolutionized cancer research, generating vast amounts of data.
Purpose of the Study:
- To review the classification and genetic alterations of cutaneous melanoma.
- To discuss the impact of genetic alterations on targeted melanoma therapies.
- To present recent high-throughput genomic technologies, evaluating their pros and cons for melanoma research.
Main Methods:
- Review of current literature on cutaneous melanoma classification and genetics.
- Analysis of the impact of genetic alterations on targeted therapies.
- Description and comparison of various high-throughput genomic technologies for cancer profiling.
Main Results:
- Melanoma classification and key genetic alterations are detailed.
- The relationship between genetic mutations and the efficacy of targeted therapies is established.
- Advantages and disadvantages of emerging genomic technologies for melanoma studies are highlighted.
Conclusions:
- Genomic technologies offer powerful tools for advancing melanoma research and understanding.
- Identifying optimal genomic technologies will aid in addressing critical questions in melanoma.
- Translating genomic insights into clinical practice can lead to personalized medicine and improved patient outcomes for melanoma.

